Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PARP inhibitors and their evolving role for the treatment of prostate cancer

Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi

PARP inhibitors and their evolving role for the treatment of prostate cancer ( Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi )

KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer

Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan

KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer ( Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan )

Disparities in access to oncology clinical trials across Europe

Prof Ana Carneiro - Lund University, Lund, Sweden

Disparities in access to oncology clinical trials across Europe ( Prof Ana Carneiro - Lund University, Lund, Sweden )

ESMO 2020: Latest updates in prostate cancer

Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Johann De Bono and Prof Nick...

ESMO 2020: Latest updates in prostate cancer ( Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Johann De Bono and Prof Nick James )

ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients...

Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA

ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC ( Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA )

ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer...

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Breast cancer roundup from ESMO 2020

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Breast cancer roundup from ESMO 2020 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

OncoAlert and ecancer weekly roundup for September 14-19, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for September 14-19, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer

Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA

IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer ( Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA )

ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer

Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan

ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer ( Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan )

Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1...

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain

Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004 ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )

Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC...

Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan

Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC after tumour resection ( Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan )

More from ecancer